preproenkephalin and Cardiomyopathies

preproenkephalin has been researched along with Cardiomyopathies* in 3 studies

Other Studies

3 other study(ies) available for preproenkephalin and Cardiomyopathies

ArticleYear
Nuclear opioid receptors activate opioid peptide gene transcription in isolated myocardial nuclei.
    The Journal of biological chemistry, 1998, May-29, Volume: 273, Issue:22

    Opioid-binding sites were identified in highly purified nuclei isolated from hamster ventricular myocardial cells. A significant increase in the maximal binding capacity for a kappa opioid receptor ligand was observed in myocardial nuclei from BIO 14.6 cardiomyopathic hamsters, as compared with nuclei obtained from normal myocytes of the F1B strain. The exposure of isolated nuclei to dynorphin B, a natural agonist of kappa opioid receptors, markedly increased opioid peptide gene transcription. The transcriptional effect was mediated by nuclear protein kinase C activation and occurred at a higher rate in nuclei from cardiomyopathic myocytes than in nuclei isolated from normal cells. Thus, a nuclear endorphinergic system may play an intracrine role in the regulation of gene transcription under both normal and pathological conditions.

    Topics: Animals; Cardiomyopathies; Cell Nucleus; Cricetinae; Enkephalins; Gene Expression Regulation; In Vitro Techniques; Male; Mesocricetus; Opioid Peptides; Protein Kinase C; Protein Precursors; Receptors, Cytoplasmic and Nuclear; Receptors, Opioid, kappa; Transcription, Genetic

1998
Expression of the preproenkephalin A gene in the heart of cardiomyopathic hamsters.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 1991, Volume: 69, Issue:7

    The expression of the preproenkephalin A gene (Enk gene), which codes for the precursor of enkephalins, was investigated in the heart of hamsters with a hereditary cardiomyopathy at four different stages of the disease: the prenecrotic stage (30 days), the necrotic stage (60 days), the hypertrophic stage (120 days), and the final stage (200 days). In control atria and ventricles, the relative abundance of the Enk mRNA, as assessed by Northern blot analysis, did not change upon ageing. In the ventricles of cardiomyopathic hamsters, however, it increased about two- to three-fold at the necrotic stage, but was unaltered at the other time points studied; whereas in the atria, it progressively decreased to reach about half that of control hamsters at the final stage. Enkephalin levels, as measured by radioimmunoassay, decreased at 60 days in both the atria and ventricles of control hamsters, and also in the atria of cardiomyopathic hamsters, and remained stable thereafter, corresponding to one-third to one-half of those at 30 days. However, in the ventricles of cardiomyopathic hamsters, the peptide level decreased only slightly, the consequence being that at 60, 120, and 200 days, it was about two- to three-fold that of control hamsters. The lack of correlation between peptide levels and the relative abundance of the Enk mRNA suggests that translational and (or) post-translational mechanisms are important in the control of the expression of the Enk gene in the heart of hamsters.

    Topics: Aging; Amino Acid Sequence; Animals; Blotting, Northern; Cardiomyopathies; Cricetinae; Enkephalin, Methionine; Enkephalins; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Atria; Heart Ventricles; Male; Molecular Sequence Data; Protein Precursors; Radioimmunoassay; RNA, Messenger

1991
Increase in the relative abundance of preproenkephalin A messenger RNA in the ventricles of cardiomyopathic hamsters.
    Biochemical and biophysical research communications, 1988, Aug-30, Volume: 155, Issue:1

    Preproenkephalin A messenger RNA was detected in hamster heart by Northern blot analysis using a human preproenkephalin A cDNA probe. Ventricular levels of this messenger were one order of magnitude lower than atrial levels, which were equivalent to brain levels. Furthermore, in the heart of cardiomyopathic hamsters, an animal model of cardiac hypertrophy and congestive heart failure, the relative abundance of the preproenkephalin A messenger RNA was found to increase three- to four-fold in ventricles while no change was seen in atria. These results support the hypothesis that the heart has the potential for locally synthesizing enkephalins and provide evidence that alterations in preproenkephalin A messenger RNA levels are associated with the development of cardiac hypertrophy and failure.

    Topics: Animals; Autoradiography; Cardiomyopathies; Cloning, Molecular; Cricetinae; Enkephalins; Heart Ventricles; Immunoassay; Male; Mesocricetus; Protein Precursors; RNA, Messenger; Transcription, Genetic

1988